Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Karyopharm Therapeut (KPTI)

Karyopharm Therapeut (KPTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,095,686
  • Shares Outstanding, K 62,790
  • Annual Sales, $ 30,340 K
  • Annual Income, $ -178,410 K
  • 60-Month Beta 2.60
  • Price/Sales 37.34
  • Price/Cash Flow N/A
  • Price/Book 18.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.67
  • Number of Estimates 6
  • High Estimate -0.61
  • Low Estimate -0.74
  • Prior Year -0.96
  • Growth Rate Est. (year over year) +30.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.88 +25.74%
on 11/06/19
18.70 -6.68%
on 11/29/19
+3.28 (+23.15%)
since 11/05/19
3-Month
8.91 +95.74%
on 10/01/19
18.70 -6.68%
on 11/29/19
+8.00 (+84.66%)
since 09/05/19
52-Week
3.92 +345.15%
on 03/01/19
18.70 -6.68%
on 11/29/19
+6.89 (+65.25%)
since 12/04/18

Most Recent Stories

More News
Shares of Karyopharm Thera Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (KPTI , EXEL , CLVS , VRTX , ALXN )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CLVS : 8.86 (-26.90%)
EXEL : 17.15 (-2.94%)
KPTI : 17.45 (-3.27%)
Karyopharm Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Karyopharm Therapeutics Inc. (Nasdaq: KPTI), an oncology-focused pharmaceutical company, today announced that the Compensation Committee of Karyopharm's Board of Directors granted stock options to purchase...

KPTI : 17.45 (-3.27%)
Are You Looking for a Top Momentum Pick? Why Karyopharm Therapeutics (KPTI) is a Great Choice

Does Karyopharm Therapeutics (KPTI) have what it takes to be a top stock pick for momentum investors? Let's find out.

KPTI : 17.45 (-3.27%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Cytomx Therapeut (CTMX , SPPI , KPTI , CYTK , ALNY )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CTMX : 6.13 (-5.84%)
KPTI : 17.45 (-3.27%)
SPPI : 9.50 (+0.32%)
After Yesterday's Rally of 4.42% Shares Could Potentially Pullback

Karyopharm Thera (NASDAQ:KPTI) traded in a range yesterday that spanned from a low of $15.50 to a high of $16.32. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high...

KPTI : 17.45 (-3.27%)
Karyopharm Thera Set to Possibly Pullback After Yesterday's Rally of 48.01%

Karyopharm Thera (NASDAQ:KPTI) traded in a range yesterday that spanned from a low of $14.60 to a high of $15.07. Yesterday, the shares gained 48.0%, which took the trading range above the 3-day high...

KPTI : 17.45 (-3.27%)
Watch for Karyopharm Thera to Potentially Pullback After Gaining 42.78% Yesterday

Karyopharm Thera (NASDAQ:KPTI) traded in a range yesterday that spanned from a low of $14.15 to a high of $14.69. Yesterday, the shares gained 42.8%, which took the trading range above the 3-day high...

KPTI : 17.45 (-3.27%)
Karyopharm Announces XPOVIO(R) (Selinexor) Clinical Data to be Presented at the American Society of Hematology 2019 Annual Meeting

-- Updated Results from the Pomalyst(R) and Kyprolis(R) Arms of the Phase 1b/2 STOMP Study Evaluating Selinexor in Combination with Other Approved Myeloma Therapies in Relapsed or Refractory Multiple Myeloma...

KPTI : 17.45 (-3.27%)
Karyopharm (KPTI) Catches Eye: Stock Jumps 6.4%

Karyopharm (KPTI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

FGEN : 47.14 (+0.77%)
KPTI : 17.45 (-3.27%)
Karyopharm Thera has the Best Relative Performance in the Biotechnology Industry (KPTI , IRWD , SRPT , TGTX , DVAX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

IRWD : 12.33 (+0.24%)
KPTI : 17.45 (-3.27%)
SRPT : 109.96 (-1.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade KPTI with:

Business Summary

Karyopharm Therapeutics, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of drugs for the treatment of cancer and other major diseases. It serves the healthcare industry throughout the United States. Karyopharm Therapeutics, Inc. is based in United States.

See More

Key Turning Points

2nd Resistance Point 18.71
1st Resistance Point 18.08
Last Price 17.45
1st Support Level 16.98
2nd Support Level 16.52

See More

52-Week High 18.70
Last Price 17.45
Fibonacci 61.8% 13.05
Fibonacci 50% 11.31
Fibonacci 38.2% 9.57
52-Week Low 3.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar